Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial
Background and Objective: In November 2019, there were abundant cases of COVID-19 which first case was reported in Wuhan, China. Colchicine has an important role in inhibiting activation of NLRP3 inflammasome that predispose to decrease cytokine production. This study aimed to evaluate whether colch...
Saved in:
| Main Authors: | Aryan Mohamadfatih Jalal, Sheelan Faroz Aref, Dashty Abbas Albustany |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=136;epage=141;aulast=Jalal |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What is the lowest lethal dose of colchicine?
by: Vanyo Mitev
Published: (2023-03-01) -
Prevalence of intestinal parasites in Erbil, Iraq
by: Chalabi K.
Published: (2024-12-01) -
Colchicine Poisoning in Children: 7 Case Reports
by: Mehmet Karacan, et al.
Published: (2009-09-01) -
High Colchicine Doses Are Really Silver Bullets Against COVID-19
by: Mitev V.
Published: (2024-12-01) -
The Superiority of Compressed Colchicine Tablets over Coated Colchicine Tablets for Familial Mediterranean Fever
by: Mehmet Nur Kaya, et al.
Published: (2024-10-01)